EichorEICHOR
Location: Richardson Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Richardson

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · University of Texas Southwestern Simmons Cancer Center - Ric · Pfizer · NCT07028853A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Phase 3 · Pillar Clinical Research - Richardson · Bristol-Myers Squibb · NCT06929273A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · UT Southwestern - Simmons Cancer Center - Richardson/Plano · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophr
Phase 1 · Pillar Clinical Research, LLC · Janssen Research & Development, LLC · NCT07615426Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · NRG Oncology · NCT05174169Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · Alliance for Clinical Trials in Oncology · NCT06931340Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients
Phase N/A · Methodist Richardson Medical Center- Clinical Research Insti · Methodist Health System · NCT07644091Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I Disorder
Phase 2 · Pillar Clinical Research - Richardson · Rapport Therapeutics Inc. · NCT07046494Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · National Cancer Institute (NCI) · NCT04269902Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NI
Phase 1 · UT Southwestern Clinical Center at Richardson/Plano · National Cancer Institute (NCI) · NCT03816345Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · UT Southwestern Clinical Center at Richardson/Plano · Alliance for Clinical Trials in Oncology · NCT06632977Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06830044A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission o
Phase 3 · Oak Cliff Research Company, LLC · Hoffmann-La Roche · NCT06094010Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · National Cancer Institute (NCI) · NCT05256225Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescent
Phase 2 · UT Southwestern Clinical Center at Richardson/Plano · National Cancer Institute (NCI) · NCT06900595Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
NA · The University of Texas at Dallas · The University of Texas at Dallas · NCT05958381Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · NRG Oncology · NCT05646316A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Dep
Phase 2 · Pillar Clinical Research - Richardson /ID# 276764 · AbbVie · NCT07276997Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · UT Southwestern Clinical Center at Richardson/Plano · National Cancer Institute (NCI) · NCT07061964Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · UT Southwestern Clinical Center at Richardson/Plano · NRG Oncology · NCT05327686A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Featur
Phase 3 · Pillar Clinical Research - Richardson · Bristol-Myers Squibb · NCT07140913Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Phase 3 · Reviva site · Reviva Pharmaceuticals · NCT05184335mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · Alliance for Clinical Trials in Oncology · NCT05677490Brain Health on College Campuses
NA · University of Texas at Dallas · The University of Texas at Dallas · NCT06724887Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · National Cancer Institute (NCI) · NCT05987241Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · ECOG-ACRIN Cancer Research Group · NCT04423211Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head
Phase 2 · UT Southwestern Clinical Center at Richardson/Plano · ECOG-ACRIN Cancer Research Group · NCT02734537A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
Phase 3 · Pillar Clinical Research LLC (Richardson, TX) Site · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT06894212S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac
Phase 3 · UT Southwestern Clinical Center at Richardson/Plano · SWOG Cancer Research Network · NCT03418961Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Sympt
Phase 3 · Pillar Clinical Research, LLC · Minerva Neurosciences · NCT07565428
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.